This was the method used in the earlier cases in this series, the relaxant being reversed with adequate doses of atropine and neostigmine, but there was nevertheless a troublesome incidence of inadequate reversal. There are, in the case of d-tubocurarine, good reasons, apart from any consideration of acidosis or hypermagnesemia, why this should be so: normally the liver excretes only about 11 % of a dose of the drug, the rest being removed by renal clearance (Fleischli & Cohen 1966) . The degree of neuromuscular block can be related to plasma levels. In nephrectomized animals these are markedly increased for many hours after injection (Cohen et al. 1967) .
Reversal difficulties with competitive blockers lead to consideration of suxamethonium as an alternative relaxant. The problem here is that in normal patients a single dose produces a rise of serum potassium of the order of 0.5-0.7 mEq/l. and its use has been considered to be totally contraindicated in renal patients (Roth & Wuthrich 1969) , though this view has been challenged (Miller et al. 1972) .
Most anmsthetists, faced with a patient with a full stomach, would opt to facilitate intubation by using suxamethonium, and it is a small step from this to prolong the action of the initial dose with tetrahydroaminacrine (THA).
In this series relaxation was produced in 63 cases by suxamethonium prolonged by THA. In 9 patients a single dose of 100 mg or less of suxamethonium was used, in a further 24 cases two doses only, not exceeding 200 mg; the remainder received further increments, the highest total reached in one case being 400 mg. The initial dose of THA was 15 mg, and total dosage did not exceed 30 mg.
Blood samples for serum potassium determination were withdrawn through an external jugular venous catheter in 27 of these cases, and levels were determined before each injection of suxamethonium and at 2, 5 and 10 minutes afterwards. The electrocardiograph was monitored throughout in all cases. The greatest increase in serum potassium after an initial dose of suxamethonium was 0.7 mEq/l.; after subsequent injections, the increase did not exceed 0.5 mEq/1. and was generally lower; the largest total increase in serum potassium from the beginning to the end of an operation was 1.2 mEq/l. Where multiple doses of suxamethonium were given, the later ones were accompanied by 4 ml of 10% calcium chloride.
Cardiac arrest of about 10 seconds duration occurred in one patient about 2 minutes after a second injection of suxamethonium. The heart restarted immediately external massage was begun. Serum potassium at this time was 5.4 mEq/litre but serum sodium, at 120 mEq/litre, was the lowest in the series. Clearly this tech-nique is contraindicated if serum potassium is initially high. The patients were returned to the ward to be barrier nursed in single rooms, and oxygen was administered postoperatively for many hours by disposable mask. The absence of any residual paralysis once the last dose of suxamethonium had worn off in the operating theatre was striking, but great care must be taken whenever this technique is used. In Cambridge we have given over 500 anmesthetics to renal transplant patients, the majority receiving suxamethonium to assist intubation. As far as I am aware there have been no complications attributable to its use. However, in view of doubts expressed by Powell (1970) and others, Dr Jill Walton and I have made measurements of serum potassium in 12 patients; 10 of these had recently been dialysed, and 2 had functioning renal grafts. In the majority the serum potassium rose by less than 0.7 mEq/litre within two or three minutes of receiving 1 mg/kg suxamethonium. One patient with an initial control level of 3.0 showed a rise of 1.0 mEq/litre. This confirms the findings of other workers. However, one patient undergoing bronchoscopy showed no rise at all after the initial dose, but after a second dose of 0.5 mg/kg two minutes later the level rose by 2.8 mEq/litre. Powell's case showed a similar rise after a repeated dose, while Koide & Waud (1972) reported a case in which serum potassium rose by 0.2 mEq/litre after the first dose and by a further 1.0 mEq/litre after a second dose. This led us to hypothesize that dangerous increases in serum potassium were unlikely after single doses of suxamethonium but might occur after repeated doses. We cannot explain Dr Smith's findings except to suggest the possibility that THA might prevent release of potassium from muscle cells.
